Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neutrophil cytosol factor 1 (NCF1), commonly known as p47phox, is a critical cytosolic subunit of the multi-protein NADPH oxidase (NOX2) complex responsible for generating reactive oxygen species (ROS) (UniProt P14598). The Phox homology (PX) domain of p47phox plays a pivotal role in this process by mediating the protein's recruitment to the plasma or phagosomal membrane through specific interactions with phosphoinositides, particularly PI(3)P and PI(3,4)P2 (PubMed: 11739770). Upon cell activation, p47phox undergoes phosphorylation, triggering a conformational change that exposes the PX and SH3 domains, allowing the cytosolic complex to assemble with the membrane-bound cytochrome b558 (PubMed: 15590945). This assembly is essential for the production of superoxide anions, which are vital for microbial killing but can also drive tissue damage if dysregulated (PubMed: 17449725). Consequently, p47phox is a significant therapeutic target for inflammatory and autoimmune conditions where oxidative stress is a primary driver, such as rheumatoid arthritis and cardiovascular diseases (PubMed: 24659618). Conversely, genetic deficiencies in NCF1 lead to chronic granulomatous disease, highlighting its essential role in the innate immune response (NIH: Genetic Home Reference).
Inhibition of NADPH oxidase complex assembly by disrupting the translocation of p47phox to the membrane or its interaction with p22phox (PubMed: 24659618).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neutrophil cytosol factor 1 (NCF1) (NCF1).